ROYAL BANK OF CANADA

Holdings History for MADRIGAL PHARMACEUTICALS, INC. - COM (MDGL)

Symbol: MDGL on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$2.05M	9.65K	+1,273	+15.2%	$212.06	Q3 2024
6/30/2024	0%	+0%	$2.35M	8.38K	+5,864	+234%	$280.24	Q2 2024
3/31/2024	0%	0%	$671K	2.51K	-4,204	-62.6%	$267.22	Q1 2024
12/31/2023	0%	+0%	$1.55M	6.72K	+4,493	+202%	$231.27	Q4 2023
9/30/2023	0%	0%	$324K	2.22K	-9,166	-80.5%	$145.81	Q3 2023
6/30/2023	0%	0%	$2.63M	11.4K	-1,583	-12.2%	$230.94	Q2 2023
3/31/2023	0%	0%	$3.14M	13K	-179	-1.36%	$242.31	Q1 2023
12/31/2022	0%	+0%	$3.82M	13.2K	+2,570	+24.3%	$290.27	Q4 2022
9/30/2022	0%	+0%	$688K	10.6K	+83	+0.79%	$65.03	Q3 2022
6/30/2022	0%	0%	$751K	10.5K	-652	-5.85%	$71.54	Q2 2022
3/31/2022	0%	0%	$1.09M	11.1K	-1,961	-15%	$98.13	Q1 2022
12/31/2021	0%	+0%	$1.11M	13.1K	+5,237	+66.5%	$84.67	Q4 2021
9/30/2021	0%	+0%	$629K	7.87K	+174	+2.26%	$79.89	Q3 2021
6/30/2021	0%	+0%	$751K	7.7K	+7,332	+1998%	$97.55	Q2 2021
3/31/2021	0%	+0%	$43K	367	+223	+155%	$117.17	Q1 2021
12/31/2020	0%	+0%	$16K	144	+18	+14.3%	$111.11	Q4 2020
9/30/2020	0%	+0%	$15K	126	+65	+107%	$119.05	Q3 2020
6/30/2020	0%	0%	$7K	61	-29	-32.2%	$114.75	Q2 2020
3/31/2020	0%	0%	$6K	90	-265	-74.6%	$66.67	Q1 2020
12/31/2019	0%	+0%	$33K	355	+263	+286%	$92.96	Q4 2019
9/30/2019	0%		$8K	92			$86.96	Q3 2019
6/30/2019	0%	0%	$10K	92	-30	-24.6%	$108.70	Q2 2019
3/31/2019	0%	0%	$15K	122	-11	-8.27%	$122.95	Q1 2019
12/31/2018	0%	0%	$15K	133	-258	-66%	$112.78	Q4 2018
9/30/2018	0%	0%	$83K	391	-8,900	-95.8%	$212.28	Q3 2018
6/30/2018	0%	0%	$2.6M	9.29K	-13	-0.14%	$279.63	Q2 2018
3/31/2018	0%	0%	$1.09M	9.3K	-97	-1.03%	$116.83	Q1 2018
12/31/2017	0%	0%	$863K	9.4K	-152	-1.59%	$91.80	Q4 2017
9/30/2017	0%	+0%	$430K	9.55K	+9,369	+5092%	$45.01	Q3 2017
6/30/2017	0%		$3K	184			$16.30	Q2 2017
3/31/2017			$1K	42			$23.81^*	Q1 2017
12/31/2016			$1K	42			$23.81^*	Q4 2016
9/30/2016			$1K	42			$23.81^*	Q3 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.